Journal Collaborations & Media Partners
The NextGen Omics Series marketing team work with leading journal publications on reciprocal marketing arrangements.
If you are interested in promoting your journal/association to the leading players in this industry please contact us.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
www.bio-equip.com was established in the early days of the Internet, in July 1998. Over the last two decades, themed on "serving life sciences and serving high quality suppliers", Bio-equip has provided the users in the fields of life sciences, medicine research, biological pharmacy, bio-engineering, modern agriculture, food safety, environmental monitoring and forensic science with the industrial information in terms of devices and instruments, reagents, consumables, lab animals, cell lines, books, biological R&D service, second-hand instruments and instrument repairs.
There are two versions, the Chinese version (bio-equip.com) and English version (bio-equip.cn): So far over 30,000 companies have registered as members and provided over 1 million product entries in the Chinese version (www.bio-equip.com), The daily visits exceed over 60,000.. The English version (www.bio-equip.cn), established in 2006, is the only English website in this field. Until August 2018, over 1,000 companies from both at home and abroad have registered as members, covering the fields of manufacturing, sale and agency of instruments/reagents with over 100,000 product entries.
Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here ebooks.benthamscience.com. Bentham Science is offering 20% discounts on purchasing eBooks and subscriptions on Journals to delegates attending the conference. TO AVAIL, QUOTE “BSPCNF2019” at www.eurekaselect.com or email at email@example.com. For more information: benthamscience.com/index.php
pharmaphorum media was launched with the mission being to help all healthcare stakeholders communicate, connect and collaborate in order to drive medical innovation and deliver better outcomes for patients, with the pharmaceutical industry being at the core of this.
Genes (ISSN 2073-4425, IF 3.331), an international, peer-reviewed open access journal on genetics and genomics who publishes reviews, research articles, communications and technical notes on the following topics of interest, but are not limited to:
• DNA; RNA
• genetic code; gene structure; gene expression
• chromosomes; recombination and linkage; genetic mapping
• transcriptional profiling; analysis of noncoding and other RNAs
• cloning; genetically modified organisms
• human genetics; medical genetics; gene therapy; personal medicine
• population genetics; conservation genetics; phylogenomics; phylogenetics
• genome projects; genomics
• sequencing technologies; bioinformatics
Genes was launched in 2010 and has published more than 2500 peer-reviewed manuscripts freely available on our website. Our journal is led by more than 300 international editorial boards covering all the fields of genetics and genomics and currently ranked 61/174 (Q2) in Journal Citation Reports® in the “Genetics & Heredity-SCIE” category.
PharmaVision offers a consultancy service providing high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. The research reports combine in-depth interviews with key opinion leaders, scientific analysis with market models to forecast the potential growth of key developmental products and technologies, identify marker drivers/resistors and identify unique selling features to guide product development
Cold Spring Harbor Laboratory Press is an internationally renowned publisher of books, journals, and electronic media, located on Long Island, New York. Since 1933, it has furthered the advance and spread of scientific knowledge in all areas of genetics and molecular biology, including cancer biology, plant science, bioinformatics, and neurobiology. It is a division of Cold Spring Harbor Laboratory, an innovator in life science research and the education of scientists, students, and the public.
BiopharmaTrend.com is a market analytics agency providing in-depth insights about emerging companies, technologies, innovations and trends in the pharmaceutical and biotech industries. We are building BPT Analytics platform -- an interactive market research and report generation tool, which automatically maps and visualizes information about the industry. It allows identifying industry partnership opportunities, tech vendors and CROs, business growth ideas, M&A and investment prospects, and much more. We also publish insightful commentaries and reviews contributed by industry professionals, researchers, and business leaders.
Cardea Bio is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors (“Cardean transistors”). Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. Until now, life science data was comprised of static snapshot datasets. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type and quality of biological data they capture by building products that Conduct Biology™. Cardea is headquartered in San Diego, California.
BlueSEQ is a specialized global consulting firm focused on Life Sciences, Digital Biology and Genomics markets. Their unique bland of Business Management , Technology Understanding and Strategy and Execution capabilities is what separates them form other consulting firms. The BlueSEQ Partners group offers customized consulting teams to help their clients gain access to relevant industry C-level expertise, which many of their consultants have achieved over many years' worth of successful management and scientific operations.
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.
"Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines."